This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Coronary Revascularization in Diabetic Patients: Optimizing Outcomes in 2006
* Case
* NRMI: DM Prevalence
* Atherosclerosis in DM
* Effect of DM on Short- & Long-term Outcomes of PCI
* Restenosis & Mortality in DM Pts
* Optimizing Outcomes in Diabetic PCI
* Optimizing Outcomes in Diabetic PCI: DES
* CYPHER: DM Subgroup
* SIRIUS: Efficacy in IDDM
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, David Cohen, MD, has indicated that he receives research/grant Support
from Cordis, Boston Scientific, Eli Lilly, The Medicines Company, BMS and sanofi-aventis.
|
|